The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes

[1]  J. Horowitz,et al.  Differentiation of Solid Renal Tumors with Multiparametric MR Imaging. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[2]  Haiyi Wang,et al.  Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics , 2017, Scientific Reports.

[3]  A. Farooqi,et al.  Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade , 2017, International Urology and Nephrology.

[4]  J. Cho,et al.  Angiomyolipoma with minimal fat: differentiation of morphological and enhancement features from renal cell carcinoma at CT imaging , 2016, Acta radiologica.

[5]  A. A. Abdel Razek,et al.  Assessment of Semiquantitative Parameters of Dynamic Contrast-Enhanced Perfusion MR Imaging in Differentiation of Subtypes of Renal Cell Carcinoma , 2016, Polish journal of radiology.

[6]  J. Cadeddu,et al.  Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. , 2016, Clinical genitourinary cancer.

[7]  M. McInnes,et al.  Angiomyolipoma (AML) without visible fat: Ultrasound, CT and MR imaging features with pathological correlation , 2016, European Radiology.

[8]  B. K. Park,et al.  Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI. , 2014, AJR. American journal of roentgenology.

[9]  I. Pedrosa,et al.  MRI Phenotype in Renal Cancer: Is It Clinically Relevant? , 2014, Topics in magnetic resonance imaging : TMRI.

[10]  B. Kolarić,et al.  Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches , 2013, International Urology and Nephrology.

[11]  Berthold Kiefer,et al.  Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. , 2012, Radiology.

[12]  A. Goyal,et al.  Diffusion-weighted MRI in renal cell carcinoma: A surrogate marker for predicting nuclear grade and histological subtype , 2012, Acta radiologica.

[13]  A. D. Van den Abbeele,et al.  Imaging in renal cell carcinoma. , 2011, Hematology/oncology clinics of North America.

[14]  C. Wood,et al.  Renal cell carcinoma: what the surgeon and treating physician need to know. , 2011, AJR. American journal of roentgenology.

[15]  E. Kocakoç,et al.  Ability and utility of diffusion-weighted MRI with different b values in the evaluation of benign and malignant renal lesions. , 2011, Clinical radiology.

[16]  A. Prando.  Renal cell carcinoma : diffusion-weighted MR imaging for subtype differentiation at 3 . 0 , 2011 .

[17]  Hersh Chandarana,et al.  Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. , 2010, AJR. American journal of roentgenology.

[18]  Aitao Guo,et al.  Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. , 2010, Radiology.

[19]  Ulrich Mödder,et al.  Statistical evaluation of diffusion‐weighted imaging of the human kidney , 2010, Magnetic resonance in medicine.

[20]  E. Remer,et al.  Clinical and radiologic features of cystic renal masses. , 2009, AJR. American journal of roentgenology.

[21]  Bachir Taouli,et al.  Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. , 2009, Radiology.

[22]  Ivan Pedrosa,et al.  Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. , 2009, Radiology.

[23]  T. Choueiri,et al.  Recent advances in the systemic treatment of metastatic papillary renal cancer , 2009, Expert review of anticancer therapy.

[24]  P. Olbert,et al.  Metastatic non‐clear cell renal cell carcinoma: current therapeutic options , 2008, BJU international.

[25]  S. Bhatt,et al.  Renal multidector row CT. , 2005, Radiologic clinics of North America.

[26]  H. Shinmoto,et al.  Angiomyolipoma: imaging findings in lesions with minimal fat. , 1997, Radiology.